Merck results beat expectations despite a big drop in sales of Covid antiviral treatment

Argentina Noticias Noticias

Merck results beat expectations despite a big drop in sales of Covid antiviral treatment
Argentina Últimas Noticias,Argentina Titulares
  • 📰 CNBC
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 72%

Merck on Thursday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations.

Still, revenue fell 9% year over year due to a steep drop in sales of Covid antiviral treatment molnupiravir.In this articleMedicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.on Thursday reported first-quarter revenue and adjusted earnings that topped Wall Street's expectations, despite a steep drop in sales of its Covid antiviral treatment molnupiravir.reported for the first quarter of 2022.

Merck's stock edged higher Thursday. The shares are up more than 2% for the year, putting the company's market value at nearly $288 billion.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

CNBC /  🏆 12. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

WSJ News Exclusive | Wall Street’s New Trade: Covid-19 Insurance ClaimsWSJ News Exclusive | Wall Street’s New Trade: Covid-19 Insurance ClaimsA number of prominent hedge funds have been buying portions of companies’ claims against their insurers for losses suffered in Las Vegas and elsewhere during the pandemic
Leer más »

Merck Keeps Striking Out on Expanding Its Cancer-Drug JuggernautKeytruda has been a gold mine for Merck—but the cancer drug’s patent is running out, and the company has struck out on many prospective new uses
Leer más »

Merck stock pops premarket after Q1 earnings beatMerck stock pops premarket after Q1 earnings beatMerck & Co. Inc.’s stock rose 2% premarket Thursday, after the company posted better-than-expected first-quarter earnings and offered guidance that topped...
Leer más »

Meta Platforms stock rallies on results, Mobileye Global stock sinks and other stocks on the moveMeta Platforms stock rallies on results, Mobileye Global stock sinks and other stocks on the moveCaterpillar and Merck & Co’s stock rise after reporting quarterly results.
Leer más »

Merck beats first-quarter expectations on Keytruda, Gardasil strengthMerck beats first-quarter expectations on Keytruda, Gardasil strengthDrugmaker Merck & Co Inc on Thursday posted better-than-expected results for the first quarter on the strength of its blockbuster cancer immunotherapy Keytruda and human papillomavirus (HPV) vaccine Gardasil.
Leer más »

Meta Q1 Sales Up 3% as Social Giant Beats Wall Street EstimatesMeta Q1 Sales Up 3% as Social Giant Beats Wall Street EstimatesMeta, parent of Facebook and Instagram, turned in better-than-expected earnings for the first quarter of 2023 — even as net income dropped sharply on a year-over-year basis. Overall, the comp…
Leer más »



Render Time: 2025-04-18 17:12:42